通报号: G/TBT/N/USA/1121 |
ICS号: 11.020
|
发布日期: 2016-05-09
|
截至日期: 2016-07-18
|
通报成员: 美国
|
目标和理由: 保护消费者;防止欺诈行为
|
内容概述: 食品药品管理局(FDA或我们)现提出修订涉及标注日期的生物产品通用标准,撤销涉及标准准备和效力限制的某些标准。FDA提出本措施以便更新过时的要求,适应新的发展中的技术和测试能力,同时不降低公众健康保护。本措施提案是FDA为回应行政法令而回顾检查法规的一部分。
|
正文:
世界贸易组织 |
G/TBT/N/USA/1121
2016-05-09
16-2554
|
|
技术性贸易壁垒 |
原文:英语
|
通 报
以下通报根据TBT协定第10.6条分发
1. |
通报成员: 美国
如可能,列出涉及的地方政府名称 ( 3.2条和7.2 条):
|
2. |
负责机构:卫生及公共服务部(HHS)食品药品管理局(FDA)[1139]
|
3. |
通报依据条款:
[X] 2.9.2
[ ] 2.10.1
[ ] 5.6.2
[ ] 5.7.1
通报依据的条款其他:
|
4. |
覆盖的产品: 生物产品。数学。自然科学 (词汇),医学科学和卫生保健设施综合。 ICS: 01.040.07、11.020 HS:
HS编码: ICS编码:11.020
|
5. |
通报标题: 标准准备、效力限制和生物产品标注日期限制;直接最终法规手册。
语言:英语 页数:7 链接网址:
|
6. |
内容简述: 食品药品管理局(FDA或我们)现提出修订涉及标注日期的生物产品通用标准,撤销涉及标准准备和效力限制的某些标准。FDA提出本措施以便更新过时的要求,适应新的发展中的技术和测试能力,同时不降低公众健康保护。本措施提案是FDA为回应行政法令而回顾检查法规的一部分。
|
7. |
目标与理由:防止欺诈行为和消费者保护。
|
8. |
|
9. |
拟批准日期:待定
拟生效日期:待定
|
10. |
意见反馈截止日期: 2016/07/18
|
11. |
文本可从以下机构得到:
[ ] 国家通报机构
[ ] 国家咨询点,或其他机构的联系地址、传真及电子邮件地址(如能提供):
|
|
正文(英):
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6
1.
|
Notifying Member: United States of America
If applicable, name of local government involved (Article 3.2 and 7.2):
|
2.
|
Agency responsible: Food and Drug Administration (FDA), Health and Human Services (HHS) [1139]
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above: Please submit comments to: USA WTO TBT Enquiry Point, Email: usatbtep@nist.gov
|
3.
|
Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], other:
|
4.
|
Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Biological products. Mathematics. Natural sciences (Vocabularies) (ICS 01.040.07), Medical sciences and health care facilities in general (ICS 11.020)
|
5.
|
Title, number of pages and language(s) of the notified document: Standard Preparations, Limits of Potency, and Dating Period Limitations for Biological Products; Companion to Direct Final Rule (7 pages, in English).
|
6.
|
Description of content: The Food and Drug Administration (FDA or Agency or we) is proposing to amend the general biological products standards relating to dating periods and also to remove certain standards relating to standard preparations and limits of potency. FDA is proposing this action to update outdated requirements, and accommodate new and evolving technology and testing capabilities, without diminishing public health protections. This proposed action is part of FDA's retrospective review of its regulations in response to an Executive order.
|
7.
|
Objective and rationale, including the nature of urgent problems where applicable: Prevention of deceptive practices and consumer protection
|
8.
|
Relevant documents: 81 Federal Register (FR) 26753, 4 May 2016; Title 21 Code of Federal Regulations (CFR) Part 610. Will appear in the Federal Register when adopted.
Direct Final Rule published 4 May 2016 will be issued as Add.1:
https://www.gpo.gov/fdsys/pkg/FR-2016-05-04/html/2016-10385.htm
https://www.gpo.gov/fdsys/pkg/FR-2016-05-04/pdf/2016-10385.pdf
|
9.
|
Proposed date of adoption: To be determined
Proposed date of entry into force: To be determined
|
10.
|
Final date for comments: 18 July 2016
|
11.
|
Texts available from: National enquiry point [ ] or address, telephone and fax numbers and email and website addresses, if available, of other body:
https://members.wto.org/crnattachments/2016/TBT/USA/16_1849_00_e.pdf
|
|
|
|
|
|
|
本网维权及免责声明:
①凡本网所有原始/编译文章及图片、图表的版权均属江苏省技术性贸易措施信息平台(www.tbtguide.com)所有,如要转载,需注明"信息来源:江苏省技术性贸易措施信息平台"或"信息来源:tbtguide"。违反上述规定者,本网将保留追究其侵权责任的权利。
②凡本网注明"信息来源:XXX(非tbtguide)"的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
联系E-mail:js_wto@163.com |